Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015.

Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015. J Clin Oncol. 2016 Jan 10; 34(2):179-85.

View in: PubMed

subject areas

Antibodies, Monoclonal
Antineoplastic Agents
Clinical Trials as Topic
Colorectal Neoplasms
ErbB Receptors
Exons
Genes, ras
Genetic Testing
GTP Phosphohydrolases
Humans
Membrane Proteins
Meta-Analysis as Topic
Molecular Targeted Therapy
Mutation
Predictive Value of Tests
Proto-Oncogene Proteins p21(ras)
Retrospective Studies

authors with profiles

Richard Schilsky